Home › Bronchiolitis Obliterans Syndrome › Tennessee › Nashville
Bronchiolitis Obliterans Syndrome clinical trials in Nashville, TN
4 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
RecruitingObservational study
- Vanderbilt University Medical Center, Nashville
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RecruitingPhase 3
- Sarah Cannon, Nashville
- Vanderbilt Medical Center, Nashville
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
Recruiting
- Vanderbilt Urology Cool Springs, Franklin · 17 mi away
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- Tristar Bone Marrow Transplant, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
Bronchiolitis Obliterans Syndrome trials in other cities
- Boston, MA13 studies
- Seattle, WA11 studies
- Atlanta, GA10 studies
- New York City, NY9 studies
- Houston, TX8 studies
- Los Angeles, CA7 studies
- Miami, FL7 studies
- Baldwin Park, CA6 studies
- Tampa, FL6 studies
- Durham, NC6 studies
- Philadelphia, PA6 studies
- Washington, DC6 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.